Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a generalized classification of human host factors that are essential for the life cycle of the Human Papillomavirus (HPV) and the subsequent development of dysplastic lesions. HPV relies on the host's cellular machinery for viral DNA replication and protein synthesis, primarily through the action of viral oncoproteins E6 and E7 which target key tumor suppressors like p53 and pRb. The interaction with these host factors leads to uncontrolled cell proliferation and a failure in normal tissue repair mechanisms, resulting in dysplasia. Therapeutic strategies often focus on inhibiting these host-virus interactions or restoring the function of the hijacked host proteins to promote the regression of dysplastic tissue. Understanding these factors is critical for developing targeted treatments for HPV-related conditions, including cervical intraepithelial neoplasia and various anogenital cancers.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Unknown human host factor involved in HPV proliferation and dysplastic tissue repair.